CDMOs and CROs at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

62 CDMOs and CROs are at Festival of Biologics 2026 — 26 presentations on the program and 55 with a booth in the exhibit hall. Most represented: Lonza (6 on the program), Pharmaron (2 on the program), Provis Biolabs (2 on the program). 57 of them have their own page in this guide. As of Sep 26, 2026.

All 378 organizations at Festival of Biologics 2026 →

Topic
Top represented
Showing 1–13 of 62 organizations
OrganizationFestival of Biologics 2026 Attendance
Lonza
Basel, Switzerland
CDMO & CROTitle sponsor
Contract development and manufacturing partner for biologics, cell and gene therapies and small molecules.
Booth
Exhibiting at Booth 450
Talk
Tue Oct 13
17:10
De-risking Lyophilization Scale-Up Using predictive models
How computer models of freeze-drying can predict what happens at full manufacturing scale, cutting experiments and the risk of a failed transfer.
Keynote
Wed Oct 14
09:55
From Experimentation to Prediction: How Data-Driven Innovation is Forging Predictability Across Biologics Development and Precision Biomanufacturing
Why biologics developers still decide by trial and error, and how treating every program as shared learning could make outcomes more predictable.
Bioprocessing & manufacturingAI & computational design
Talk
Wed Oct 14
12:30
Accelerating CHO Cell Line Development Through Next-Generation Expression System Design
How improved cell engineering, promoter design and selection methods shorten the path from DNA to a cell line that makes a drug.
Talk
Wed Oct 14
14:30
Beyond mAbs: accelerated Gene-to-IND development for bispecifics, Fc-fusions and high-concentration biologics
Faster routes from DNA to first clinical trials for complex antibody drugs, and the problems they create in making, purifying and formulating them.
Pharmaron
Beijing, China
CDMO & CROGold sponsor
R&D service company supporting biologics from discovery to commercialization with integrated laboratory, preclinical, development, manufacturing and regulatory services.
Booth
Exhibiting at Booth 406
Talk
Wed Oct 14
17:10
Successful CMC Development & Manufacturing is Built on Highly Effective Partnerships
Why complex biologic drugs rely on close partnerships in manufacturing and quality control to move from preclinical work to clinical supply.
Chair
Thu Oct 15
08:55
Chair's Remarks
Manufacturing
Chair
Thu Oct 15
11:15
Chair's Remarks
Manufacturing
CDMO & CRO
Indian company developing biosimilars and offering biologics CDMO services plus research- and GMP-grade recombinant reagents.
Chair
Wed Oct 14
14:05
Chair's Remarks
Industry: Regulation, Emerging Markets, and Supply Chain
Keynote
Thu Oct 15
09:30
From Molecule to Market: De-Risking Biosimilar Development and Commercialization
How to lower the risks of bringing biosimilars, close copies of approved biologic drugs, to market as approval paths grow simpler.
Selvita
Kraków, Poland
CDMO & CROBronze sponsor
Preclinical contract research organization supporting drug discovery and development studies.
Booth
Exhibiting (no floor booth listed)
Talk
Wed Oct 14
17:10
Developability of antibodies: challenges and future directions
Why many antibody drug candidates still fail late over poor stability or clumping, and how automated screening and AI could catch problems earlier.
CDMO & CRO
Clinical research organization running clinical trials and offering regulatory and market-access consulting for drug developers.
Panel
Tue Oct 13
17:30
Panel Discussion: Accelerating the Biosimilar Approval Process
Regulation · with Targeted Solutions, Gokyo Biosciences, Aretaeus
Talk
Tue Oct 13
17:50
Vaccine Regulatory and Trial Design Considerations
Regulation
CDMO & CROSilver sponsor
Develops a scalable platform for crystallizing biologic drugs in microgravity, targeting high-concentration, low-viscosity formulations.
Booth
Exhibiting (no floor booth listed)
Panel
Tue Oct 13
12:00
Booth
Exhibiting (no floor booth listed)
Talk
Tue Oct 13
15:10
Image-Based Monoclonality Assurance for Biotherapeutic Cell Lines: Evaluating Clone Outgrowth and Suspension Adaptation Following Single-Cell Isolation
How images of single seeded cells help show regulators a production cell line grew from one cell, compared across three cell types.
CDMO & CROPlatinum sponsor
Contract development and manufacturing organization for biologics, vaccines and advanced therapies.
Booth
Exhibiting at Booth 408
Keynote
Tue Oct 13
12:40
Patient-First Manufacturing: Closing the Mid-Scale Biologics Gap
Antibody Keynotes
CDMO & CROSilver sponsor
Family-owned CRDMO combining preclinical research and clinical manufacturing of therapeutic proteins from mammalian cells at one site.
Booth
Exhibiting at Booth 224
Talk
Wed Oct 14
14:50
Designing Manufacturability into Multispecifics Early: How Integrated CRDMO De-risks Biologics Programs and Accelerates Development
Why checking how easy complex biologics are to make before picking a final candidate leads to faster, cheaper, lower-risk development.
KBI Biopharma
Durham, NC
CDMO & CROBronze sponsor
Contract development and manufacturing organization for biologics, from cell line development to clinical and commercial production.
Booth
Exhibiting at Booth 294
Talk
Tue Oct 13
17:10
Smarter lead selection and faster representative material for early CMC studies
How inserting genes with a transposase and growing stable cell pools helps teams pick lead molecules and make realistic early batches sooner.
CDMO & CROAssociate sponsor
Puerto Rico-based biologics CDMO offering development, manufacturing and flexible fill-finish capacity for sponsors seeking US-made biologics.
Booth
Exhibiting (no floor booth listed)
Panel
Wed Oct 14
17:30
PANEL DISCUSSION: From Contract to Collaboration: Effective CDMO Strategies for Biopharma Manufacturing
How drug makers and contract manufacturers can work as true partners, sharing process know-how and handling changes as production scales up.
with Gokyo Biosciences, Frost & Sullivan
ProBioGen
Berlin, Germany
CDMO & CROSilver sponsor
Offers cell line development, process development and GMP manufacturing of biologics, plus glyco-engineering and viral vaccine production technologies.
Booth
Exhibiting at Booth 180
Talk
Tue Oct 13
14:30
Navigating Speed, Complexity, and Scalability in Biomanufacturing Selecting Phase-Appropriate Upstream Strategies from Rapid Platform to Intensified Processes
How a contract manufacturer matches cell culture methods to each development stage, weighing quick standard batches against more efficient continuously fed ones.
CDMO & CRO
Life sciences supplier whose CDMO and clinical services business offers integrated development, manufacturing and clinical supply for pharma and biotech.
Booth
Exhibiting at Booth 357
Talk
Tue Oct 13
17:30
The science behind robust cell line development to produce complex biologic therapies
How transposase gene insertion, AI-driven analysis and more intensive cell culture shorten the path from new cell line to first clinical trials.

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from CDMOs and CROs

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse Festival of Biologics 2026 by

Exhibit hall

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction